Finance

Lists
Why is CNSP up 3,08%?
Dive Deeper
CNSP:NASDAQ
CNS Pharmaceuticals Inc
5,35 $
+3,08%
(+0,16) 1D
13 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNSP...
Open
5,13 $
High
5,40 $
Low
5,00 $
Mkt. cap
7,82 млн
Avg. vol.
4,49 мың
Volume
0,00
52-wk high
10,54 $
52-wk low
1,90 $
EPS
-23,14 $
Beta
1,02
Shares outstanding
1,46 млн
No. of employees
8
Open
5,13 $
High
5,40 $
Low
5,00 $
Mkt. cap
7,82 млн
Avg. vol.
4,49 мың
Volume
0,00
52-wk high
10,54 $
52-wk low
1,90 $
EPS
-23,14 $
Beta
1,02
Shares outstanding
1,46 млн
No. of employees
8
News stories
From web sources and news partners
About CNS Pharmaceuticals Inc
CEO-
Employees8
Founded2017
HeadquartersХьюстон, Техас, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitecnspharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
10,00 $
+86,9%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,20 млн
3,17 млн
3,54 млн
1,20 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,06 млн
2,82 млн
1,43 млн
1,50 млн
Operating expense
3,25 млн
5,99 млн
4,98 млн
2,70 млн
Total operating expenses
3,25 млн
5,99 млн
4,98 млн
2,70 млн
Operating income
-3,25 млн
-5,99 млн
-4,98 млн
-2,70 млн
Other non operating income
-
-2,56 мың
-
-
EBT including unusual items
-3,22 млн
-5,96 млн
-4,94 млн
-2,59 млн
EBT excluding unusual items
-3,22 млн
-5,96 млн
-4,94 млн
-2,59 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,22 млн
-5,96 млн
-4,94 млн
-2,59 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
37,02 мың
35,60 мың
44,27 мың
116,00 м.
Interest expense
-2,12 мың
-2,72 мың
-6,11 мың
-4,00 мың
Net interest expenses
34,91 мың
32,88 мың
38,16 мың
112,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,25 млн
-5,99 млн
-4,97 млн
-2,69 млн
Gain or loss from assets sale
-
2,56 мың
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары